The actors involved in the consortium agreement LIGAN : CNRS, University of Lille , Genoscreen and the Pasteur Institut of Lille


The National Center for Scientific Research is a public research organization (public scientific and technological institution under the supervision of the Ministry of Higher Education, Research and Innovation). It produces knowledge and puts it at the service of society. His research areas are multiple : Biology, Chemistry, Ecology and Environment, Humanities and social sciences, Engineering and systems, Mathematics, Nuclear and particles, Physics, Information Sciences, Earth sciences and Astronomy. The CNRS plays an strong role on the international scene in the scientific world.

With nearly 32,000 people (more than 15,000 researches and around 16,000 engineers, technicians and administrators), a budget for 2015 of € 3.3 billion, including € 730 million of own resources and a presence all over France, the CNRS is active in all areas of knowledge, based on more than 1,100 research and service units.

With 20 Nobel Prize winners and 12 Fields Medal winners, the CNRS has a long tradition of excellence. The CNRS awards each year the “gold medal”, considered as the highest scientific distinction in France.

Université de Lille - Droit et Santé

The University of Lille is one of the leading European universities.
In the heart of a young and dynamic city, European Capital of Culture in 2004, the University is a dynamic institution connected with some of the world’s highest-ranking foreign universities. To guarantee students’ socio-professional integration, the University of Lille offers high quality trainings at the three-level organization of post-secondary education (Bachelor’s-Master’s-Doctorate).

Associated with major national research organizations, the University of Lille has 3,300 teaching and research staff and 66 worldwide-renown laboratories.

Excellence, interdisciplinarity and internationalization

Excellence is the bedrock of the University of Lille. The policy implemented aims to strengthen the continuum between disciplinary and interdisciplinary scientific research, in line with major societal issues. The University of Lille is developing its projects within a European research framework, particularly with North-West Europe and with many others partners around the world.


A leading Pioneer in sequencing, genotyping and bioinformatics since 2001, GenoScreen develops innovation programs that fuel its technological lead and drive the development of innovative services and products.

With GenoScreen, discover:

  • Cutting-edge services in genomics, metagenomics and bioinformatics : GenoScreen offers a wide range of solutions based on more than 18 years of experience and on a technological platform benefiting from the most powerful equipment.
  • A key player in molecular microbiology research and innovation : involved in a wide range of research programs and projects, both public and private, GenoScreen develops a portfolio of analysis and control tools in genomics, metagenomics and molecular microbiology.
  • A company at the service of Humankind and its environment : the services and innovations developed by GenoScreen aim to meet the needs of academic and industrial researchers facing various problems in the health care of humans, animals, plants and the environment sectors.

Institut Pasteur de Lille

Institut Pasteur de Lille is a private, non-profit foundation with recognized public utility status since 1898. As an international center for biomedical research, Institut Pasteur de Lille focuses on Longevity fundamental research, education and public health to ensure we live better for longer. It also plays an economic and innovation key role through its biotechnology platforms and start-ups.

Inside the Longevity Research Center, 33 research teams are engaged to develop scientific knowledge in the diseases associated with ageing:  cardiovascular or neurodegenerative diseases, infectious diseases, metabolic diseases, cancers and diabetes. The researchers also contribute to the development of new disease prevention tools and treatments with the aim of extending the period of healthy life after the age of 60. Institut Pasteur de Lille is also strengthening its strategic positioning on Longevity through its Prevention, Health and Longevity Center: health checks, international vaccination, health education, clinical studies and expertises.

As a financially and legally independent member of the Pasteur Institutes network (RIIP), Institut Pasteur de Lille is authorised/ empowered to receive donations, bequests/legacies and sponsorship for its research projects.